Patents by Inventor Travis Wilson

Travis Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140378396
    Abstract: The present disclosure provides aromatic-cationic peptide compositions and methods of using the same. The methods comprise use of the peptides in electron transport, inhibition of cardiolipin peroxidation, apoptosis inhibition and electrical conductance.
    Type: Application
    Filed: October 11, 2012
    Publication date: December 25, 2014
    Inventors: D. Travis Wilson, Hazel Szeto, Alex Birk
  • Publication number: 20140364370
    Abstract: The invention provides compositions and methods for preventing or treating an ischemia-reperfusion injury, such as occurs during acute myocardial infarction and organ transplant in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide or a pharmaceutically acceptable salt thereof, and one or more additional active agents such as cyclosporine.
    Type: Application
    Filed: February 20, 2014
    Publication date: December 11, 2014
    Applicant: Stealth Peptides International, Inc.
    Inventor: D. Travis Wilson
  • Publication number: 20140349941
    Abstract: The present disclosure provides aromatic-cationic peptide compositions and methods of using the same. The methods comprise use of the peptides in electron transport, inhibition of cardiolipin peroxidation, apoptosis inhibition and electrical conductance.
    Type: Application
    Filed: May 22, 2014
    Publication date: November 27, 2014
    Applicants: Cornell University, Stealth Peptides International, Inc.
    Inventors: D. Travis Wilson, Hazel Szeto, Alex Birk
  • Publication number: 20140341879
    Abstract: This invention provides methods of preventing or treating cardiac ischemia-reperfusion injury in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to a subject in need thereof wherein the peptide is D-Arg-26-Dmt-Lys-Phe-NH2 (SS-31).
    Type: Application
    Filed: January 7, 2014
    Publication date: November 20, 2014
    Applicant: Stealth Peptides International, Inc.
    Inventors: Kenneth Borow, D. Travis Wilson
  • Publication number: 20140294796
    Abstract: The disclosure provides compositions and methods relating to aromatic-cationic peptides. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subjects in need thereof. For example, the peptides may be administered to subjects in need of a mitochondrial-targeted antioxidant.
    Type: Application
    Filed: December 5, 2012
    Publication date: October 2, 2014
    Inventors: D. Travis Wilson, Marc W. Andersen, Elizabeth Mead
  • Publication number: 20140278419
    Abstract: A voice command definition file (VCDF) declaratively defines voice commands for an application. For example, the VCDF may include definitions for: voice commands; one or more phrases/utterances that may be said to execute each of the commands; a navigation location to navigate to within the application (e.g. a page); phrase lists containing items that may be used as a parameter in a voice command; examples; feedback; and the like. A user may say a single utterance to launch the application, navigate to the associated location of the command and execute the command. The VCDF may define multiple ways to listen for a particular command. The VCDF may be edited/defined by a user and may include a user friendly name for an application. A speech engine loads the VCDF for use such that it may recognize the commands associated with an application. The definitions may be updated during runtime.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Inventors: F. Avery Bishop, Travis Wilson, Robert Chambers, Robert Brown
  • Publication number: 20140235529
    Abstract: The present disclosure provides methods of preventing or treating renal ischemia-reperfusion injury in a mammalian subject and methods for chronic treatment of ARVD, including administering an effective amount of an aromatic-cationic peptide to a subject in need thereof. The methods include administering aromatic-cationic peptides to prevent or treat renal injury during the treatment of renal artery stenosis. The methods include administering an effective amount of an aromatic-cationic peptide to subjects in need thereof.
    Type: Application
    Filed: September 28, 2012
    Publication date: August 21, 2014
    Inventors: D. Travis Wilson, Lilach O. Lerman, Stephen C. Textor
  • Patent number: 8697657
    Abstract: The invention provides compositions and methods for preventing or treating an ischemia-reperfusion injury, such as occurs during acute myocardial infarction and organ transplant in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide or a pharmaceutically acceptable salt thereof, and one or more additional active agents such as cyclosporine.
    Type: Grant
    Filed: March 15, 2011
    Date of Patent: April 15, 2014
    Assignee: Stealth Peptides International, Inc.
    Inventor: D. Travis Wilson
  • Publication number: 20140093897
    Abstract: The present disclosure provides aromatic-cationic peptide compositions and methods of using the same. The methods comprise use of the peptides in electron transport and electrical conductance.
    Type: Application
    Filed: March 22, 2012
    Publication date: April 3, 2014
    Applicants: Stealth Peptides International, Inc., Cornell University
    Inventors: Hazel H. Szeto, Alexander V. Birk, D. Travis Wilson
  • Publication number: 20130303436
    Abstract: Disclosed herein are methods and compositions for the treatment and/or prevention of diseases or conditions comprising administration of GLP-1, and/or naturally or artificially occurring variants or analogues of GLP-1, or pharmaceutically acceptable salts thereof, alone or in combination with one or more active agents (e.g., an aromatic-cationic peptide such as D-Arg-2?6?-Dmt-Lys-Phe-NH2).
    Type: Application
    Filed: April 11, 2013
    Publication date: November 14, 2013
    Inventor: D. Travis WILSON
  • Publication number: 20130196921
    Abstract: The invention provides methods of preventing or treating cardiac ischemia-reperfusion injury in a mammalian subject. The methods provide administering aromatic-cationic peptides in effective amounts to prevent or treat an anatomic zone of no re-flow in mammalian subjects. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subjects in need thereof.
    Type: Application
    Filed: July 8, 2011
    Publication date: August 1, 2013
    Inventors: D. Travis Wilson, Kenneth Borow, Robert A. Kloner, Sharon Hale
  • Publication number: 20130195837
    Abstract: This invention provides methods of preventing or treating cardiac ischemia-reperfusion injury in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to a subject in need thereof, wherein the peptide is D-Arg-2 6-Dmt-Lys-Phe-NH2 (SS-31).
    Type: Application
    Filed: December 30, 2010
    Publication date: August 1, 2013
    Inventors: Kenneth Borow, D. Travis Wilson
  • Publication number: 20130190244
    Abstract: The invention provides methods of treating an obstructive coronary artery disease in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subjects in need thereof and performing a coronary artery bypass graft procedure on the subject.
    Type: Application
    Filed: December 30, 2010
    Publication date: July 25, 2013
    Applicant: Stealth Peptides International, Inc.
    Inventors: Kenneth Borow, D. Travis Wilson
  • Publication number: 20130059784
    Abstract: The invention provides compositions and methods for preventing or treating an ischemia-reperfusion injury, such as occurs during acute myocardial infarction and organ transplant in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide or a pharmaceutically acceptable salt thereof, and one or more additional active agents such as cyclosporine.
    Type: Application
    Filed: March 15, 2011
    Publication date: March 7, 2013
    Inventor: D. Travis Wilson
  • Publication number: 20060049220
    Abstract: A shape supporting and form maintaining device, known as a “HatNoodle”, for a cap. The cap includes two components, an essentially hemispherical crown component and an attached visor component. The aforementioned “HatNoodle” device is constructed from a resilient material and includes a bottom surface and an essentially convex top surface. The bottom surface may contain a plurality of holes that extend into, but not completely through, the material of the device and are used when installing the device into a cap. The top surface of the device contains a plurality of slots wherein each slot begins at the center of the top surface of the device and proceeds outward in a radial direction. The slots facilitate installing a cap onto the device. These slots also allow the device to better conform to the shape of the inside surface of the crown of the cap hat it resides within.
    Type: Application
    Filed: August 20, 2005
    Publication date: March 9, 2006
    Inventors: Gregory Kroll, Travis Wilson, Arthur Kroll
  • Publication number: 20060006252
    Abstract: A top cap assembly for use with tube cap assemblies in sealing access points in irrigation systems. In one implementation, a top cap is coupled to a locator component to remotely locate the tube cap assembly. The locator component includes a metallic portion, an audible response mechanism, or other device that provides indicia usable to locate the tube cap assembly. In another implementation, the top cap includes an advertisement portion configured to removably receive indicia. The advertisement portion includes a grooved insert which receives a business card or advertising label. In another implementation, the top cap and/or base collar include grooves which receive an O-ring, and a portion of the tube cap assembly compresses against the O-ring to create a watertight seal. In still another implementation, a method to identify one or more indicium of a top cap is provided according to the present invention.
    Type: Application
    Filed: July 8, 2005
    Publication date: January 12, 2006
    Inventor: C. Travis Wilson